JP6941568B2 - ヌクレアーゼを使用する野生型ｄｎａの選択的分解および突然変異体対立遺伝子の濃縮 - Google Patents

ヌクレアーゼを使用する野生型ｄｎａの選択的分解および突然変異体対立遺伝子の濃縮 Download PDF

Info

Publication number
JP6941568B2
JP6941568B2 JP2017566374A JP2017566374A JP6941568B2 JP 6941568 B2 JP6941568 B2 JP 6941568B2 JP 2017566374 A JP2017566374 A JP 2017566374A JP 2017566374 A JP2017566374 A JP 2017566374A JP 6941568 B2 JP6941568 B2 JP 6941568B2
Authority
JP
Japan
Prior art keywords
nucleic acid
wild
target
probe
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017566374A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018518967A (ja
JP2018518967A5 (enExample
Inventor
ゲラシモス マクリギオルゴス，
ゲラシモス マクリギオルゴス，
チェン ソン，
チェン ソン，
Original Assignee
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド, デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド filed Critical デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド
Publication of JP2018518967A publication Critical patent/JP2018518967A/ja
Publication of JP2018518967A5 publication Critical patent/JP2018518967A5/ja
Application granted granted Critical
Publication of JP6941568B2 publication Critical patent/JP6941568B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2017566374A 2015-06-24 2016-06-24 ヌクレアーゼを使用する野生型ｄｎａの選択的分解および突然変異体対立遺伝子の濃縮 Active JP6941568B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562183854P 2015-06-24 2015-06-24
US62/183,854 2015-06-24
PCT/US2016/039167 WO2016210224A1 (en) 2015-06-24 2016-06-24 Selective degradation of wild-type dna and enrichment of mutant alleles using nuclease

Publications (3)

Publication Number Publication Date
JP2018518967A JP2018518967A (ja) 2018-07-19
JP2018518967A5 JP2018518967A5 (enExample) 2019-07-25
JP6941568B2 true JP6941568B2 (ja) 2021-09-29

Family

ID=57585693

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017566374A Active JP6941568B2 (ja) 2015-06-24 2016-06-24 ヌクレアーゼを使用する野生型ｄｎａの選択的分解および突然変異体対立遺伝子の濃縮

Country Status (7)

Country Link
US (2) US11725230B2 (enExample)
EP (1) EP3313992B1 (enExample)
JP (1) JP6941568B2 (enExample)
AU (1) AU2016281718B2 (enExample)
CA (1) CA2990846C (enExample)
ES (1) ES2917175T3 (enExample)
WO (1) WO2016210224A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2990846C (en) 2015-06-24 2023-09-26 Dana-Farber Cancer Institute, Inc. Selective degradation of wild-type dna and enrichment of mutant alleles using nuclease
US11371090B2 (en) 2016-12-12 2022-06-28 Dana-Farber Cancer Institute, Inc. Compositions and methods for molecular barcoding of DNA molecules prior to mutation enrichment and/or mutation detection
US11174511B2 (en) 2017-07-24 2021-11-16 Dana-Farber Cancer Institute, Inc. Methods and compositions for selecting and amplifying DNA targets in a single reaction mixture
CN107893109B (zh) * 2017-11-08 2021-07-06 重庆邮电大学 一种基于移除野生型序列的低丰度基因突变富集方法
KR102086689B1 (ko) * 2018-02-06 2020-03-09 주식회사 진씨커 돌연변이 세포 유리 유전자 분리 키트 및 이를 이용한 돌연변이 세포 유리 유전자 분리 방법
WO2019195268A2 (en) 2018-04-02 2019-10-10 Grail, Inc. Methylation markers and targeted methylation probe panels
CN108531603A (zh) * 2018-05-31 2018-09-14 青岛普泽麦迪生物技术有限公司 一种用于braf基因v600e突变检测的引物对、试剂盒及其检测方法
AU2019351130B2 (en) 2018-09-27 2025-10-23 GRAIL, Inc Methylation markers and targeted methylation probe panel
CN113260451A (zh) * 2018-10-16 2021-08-13 辛辛那提大学 单分子表观遗传定位
CN109880891B (zh) * 2019-04-22 2021-07-30 上海交通大学 基于核酸酶偶联pcr原理富集低丰度dna突变的检测技术体系及应用
CA3145319A1 (en) * 2019-08-21 2021-02-25 Dana-Farber Cancer Institute, Inc. Multi-site enrichment of deletions in dna microsatellites
WO2022032194A1 (en) 2020-08-06 2022-02-10 Singular Genomics Systems, Inc. Methods for in situ transcriptomics and proteomics
WO2022032195A2 (en) 2020-08-06 2022-02-10 Singular Genomics Systems, Inc. Spatial sequencing
GB2603203A (en) * 2021-02-02 2022-08-03 Univ Heriot Watt Method for enriching nucelic acids
EP4337782A4 (en) * 2021-05-14 2025-04-02 Carmel-Haifa University Economic Corporation Ltd. A method of identifying ultra-rare genetic variants
US11993792B2 (en) 2021-05-27 2024-05-28 New England Biolabs, Inc. DNase I variants, compositions, methods, and kits
GB202111195D0 (en) * 2021-08-03 2021-09-15 Cergentis B V Method for targeted sequencing
CN114280128B (zh) * 2021-12-24 2022-11-18 清华大学 双标记gFET的制备及其在miRNA检测中的应用
CN116240200B (zh) * 2022-07-01 2025-03-11 中国科学院基础医学与肿瘤研究所(筹) 一种基于可编程核酸酶的超灵敏目标核酸富集检测方法
EP4605546A1 (en) * 2022-10-19 2025-08-27 Biofidelity Ltd Nucleic acid enrichment and detection
WO2024249961A1 (en) 2023-06-01 2024-12-05 Singular Genomics Systems, Inc. Methods and probes for detecting polynucleotide sequences in cells and tissues
WO2025029475A1 (en) * 2023-07-28 2025-02-06 Guardant Health, Inc. Methods to enrich nucleotide variants by negative selection

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661505B2 (en) 1990-05-07 1995-07-27 Tapestry Pharmaceuticals, Inc. Diagnostic applications of double D-loop formation
EP0672185A4 (en) * 1992-07-17 1997-04-23 Aprogenex Inc NUCLEIC ACID SAMPLE AND THEIR USE IN DETECTING DOUBLE-STRANDED NUCLEIC ACIDS.
US5629178A (en) 1994-10-28 1997-05-13 Genetics & Ivf Institute Method for enhancing amplification in the polymerase chain reaction employing peptide nucleic acid (PNA)
US6949340B2 (en) * 2001-03-28 2005-09-27 Creative Mines Llc Optical phase modulator
DE10158516A1 (de) 2001-11-29 2003-06-12 Focusgenomics Gmbh Verfahren zum Nachweis von Hybridisierungsereignissen in Nukleinsäuren
AU2002346662A1 (en) * 2001-12-04 2003-06-17 Euregen Llc Methods and compositions for selectively cleaving dna containing duplex acids in a complex nucleic acid mixture
EP1725682B1 (en) 2004-03-08 2015-09-09 Rubicon Genomics, Inc. Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation
US7749707B2 (en) 2005-03-01 2010-07-06 Wako Pure Chemical Industries, Ltd. Method for obtaining subtraction polynucleotide
AU2006316537A1 (en) * 2005-11-24 2007-05-31 Basf Se Chimeric keratin-binding effector proteins
US7544473B2 (en) 2006-01-23 2009-06-09 Population Genetics Technologies Ltd. Nucleic acid analysis using sequence tokens
WO2008096146A1 (en) 2007-02-07 2008-08-14 Solexa Limited Preparation of templates for methylation analysis
US20080254453A1 (en) 2007-04-12 2008-10-16 Affymetrix, Inc Analysis of methylation using selective adaptor ligation
US7749708B2 (en) 2007-09-12 2010-07-06 Transgenomic, Inc. Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule
US20100216648A1 (en) * 2009-02-20 2010-08-26 Febit Holding Gmbh Synthesis of sequence-verified nucleic acids
US10636413B2 (en) 2009-06-13 2020-04-28 Rolr, Inc. System for communication skills training using juxtaposition of recorded takes
EP2272976A1 (en) * 2009-07-06 2011-01-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for differentiation of polynucleotide strands
WO2011057354A1 (en) 2009-11-13 2011-05-19 Commonwealth Scientific And Industrial Research Organisation Epigenetic analysis
JP5795341B2 (ja) 2010-03-08 2015-10-14 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 参照ブロック配列によるｆｕｌｌＣＯＬＤ−ＰＣＲ濃縮
US9260753B2 (en) 2011-03-24 2016-02-16 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
WO2012135053A2 (en) * 2011-03-25 2012-10-04 Integrated Dna Technologies, Inc. Rnase h-based assays utilizing modified rna monomers
CA2830361C (en) 2011-03-31 2021-03-16 Dana-Farber Cancer Institute, Inc. Methods and compositions to enable multiplex cold-pcr
CN103717751A (zh) 2011-05-19 2014-04-09 塞昆纳姆股份有限公司 用于多重核酸鉴定的产品和方法
US9238836B2 (en) * 2012-03-30 2016-01-19 Pacific Biosciences Of California, Inc. Methods and compositions for sequencing modified nucleic acids
KR102126744B1 (ko) * 2013-03-14 2020-06-26 다카라 바이오 가부시키가이샤 내열성 미스매치 엔도뉴클레아제의 이용방법
CN111383715B (zh) 2013-04-17 2024-09-10 先锋国际良种公司 用于在基因组中表征dna序列组成的方法
US10913977B2 (en) 2013-07-24 2021-02-09 Dana-Farber Cancer Institute, Inc. Methods and compositions to enable enrichment of minor DNA alleles by limiting denaturation time in PCR or simply enable enrichment of minor DNA alleles by limiting the denaturation time in PCR
US9873908B2 (en) 2013-11-27 2018-01-23 Roche Molecular Systems, Inc. Methods for the enrichment of mutated nucleic acid from a mixture
EP3378952B1 (en) 2013-12-28 2020-02-05 Guardant Health, Inc. Methods and systems for detecting genetic variants
CA2990846C (en) 2015-06-24 2023-09-26 Dana-Farber Cancer Institute, Inc. Selective degradation of wild-type dna and enrichment of mutant alleles using nuclease
US11371090B2 (en) 2016-12-12 2022-06-28 Dana-Farber Cancer Institute, Inc. Compositions and methods for molecular barcoding of DNA molecules prior to mutation enrichment and/or mutation detection
CA3145319A1 (en) 2019-08-21 2021-02-25 Dana-Farber Cancer Institute, Inc. Multi-site enrichment of deletions in dna microsatellites

Also Published As

Publication number Publication date
HK1254317A1 (zh) 2019-07-19
WO2016210224A1 (en) 2016-12-29
CA2990846A1 (en) 2016-12-29
ES2917175T3 (es) 2022-07-07
JP2018518967A (ja) 2018-07-19
US11725230B2 (en) 2023-08-15
US20180187242A1 (en) 2018-07-05
EP3313992A1 (en) 2018-05-02
EP3313992B1 (en) 2022-03-23
AU2016281718A1 (en) 2017-12-14
CA2990846C (en) 2023-09-26
US20230392191A1 (en) 2023-12-07
AU2016281718B2 (en) 2022-03-31
EP3313992A4 (en) 2018-11-14

Similar Documents

Publication Publication Date Title
US20230392191A1 (en) Selective degradation of wild-type dna and enrichment of mutant alleles using nuclease
JP7112456B2 (ja) バリアント検出のための方法
JP5237126B2 (ja) ライゲーションアッセイを用いてハイスループットシークエンスに基づき遺伝子関連配列を検出する方法
CN107849603B (zh) 利用有限核苷酸组成的引物扩增
Arbeithuber et al. Artifactual mutations resulting from DNA lesions limit detection levels in ultrasensitive sequencing applications
EP1255871B1 (en) Multiplex ligatable probe amplification
JP4663118B2 (ja) ヌクレオチドの変異について核酸をスクリーニングする方法
JP2019004914A (ja) ブロッキングオリゴヌクレオチドを用いたｄｎａ増幅の方法
KR20120139780A (ko) 기준 차단 서열을 이용한 완전 ｃｏｌｄ－ｐｃｒ 풍부화
JP2018506307A (ja) 非特異的増幅産物を減少させる為の方法及び組成物
US10023908B2 (en) Nucleic acid amplification method using allele-specific reactive primer
EP4017998B1 (en) Multi-site enrichment of deletions in dna microsatellites
EP4267763B1 (en) Compositions and methods for highly sensitive detection of target sequences in multiplex reactions
WO2001044504A2 (en) Method for detecting methylated cpg-containing nucleic acid
JP5914346B2 (ja) 非メチル化核酸の選択的蓄積
HK1254317B (en) Selective degradation of wild-type dna and enrichment of mutant alleles using nuclease
HK40064470A (en) Amplification with primers of limited nucleotide composition

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190619

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190619

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200807

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210304

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210602

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210816

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210906

R150 Certificate of patent or registration of utility model

Ref document number: 6941568

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D02

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D04

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250